Emergent Biosolutions Inc (United States) is listed on the Nasdaq and has a market capitalization of $298.31 million, with shareholders equity totaling $313.20 million.
The company employs approximately 900 people and operates in the Other sector, within the Other industry.
Over the past 12 months, Emergent Biosolutions Inc reported $649.10 million in revenue, generating net income of $-260.70 million.
Key financial metrics include a P/E ratio of -1.14, a price-to-book (P/B) ratio of 0.95, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker EBS.